Health problems
Essential Thrombocythemia (ET)
Essential thrombocythemia (ET) is a rare disease of the bone marrow that causes an excessive production of platelets or thrombocytes that are the cells responsible for blood clotting.. This can increase the risk of the formation of blood clots or, in some cases, cause bleeding. The symptoms include headaches, dizziness, numbness or pain in the hands and feet. This compliant can be treated effectively with specialised medical care. You have come to the right place to learn more about ET and our treatment solutions.
The treatment of essential thrombocythemia at our hospital is based on a personalised and multidisciplinary approach. Our haematologists assess each patient individually to propose treatment adapted to age, state of health and risk of complications.
The treatment options include simple surveillance, drug therapy to reduce the number of platelets (such as hydroxyurea) and antiaggregant agents to prevent the formation of blood clots. We provide regular follow-up to monitor progress of the disease and adjust the treatment if necessary. We also provide comprehensive support, including advice on diet and psychological support to improve the quality of life of patients
If you have essential thrombocythemia, you should adopt a healthy lifestyle to reduce the cardiovascular risk: follow a healthy diet, practice a regular physical activity and do not smoke. Follow your doctor’s recommendations regarding your treatment and report any unusual symptom, such as sudden pain or numbness. Our teams are ready to support you and answer your questions at all times.
Our doctors are active on national and international committees, contributing to treatment development and guaranteeing access to the latest innovations for our patients.
- Dr. Adriano Salaroli (Haematology)
- Dr. Philippe Lewalle (Haematology)
- Dr. Elisa Brauns (Haematology)
- Dr Sebastian Wittnebel (Haematology)
- Haematology (Jules Bordet Institute)
- Internal medicine (Jules Bordet Institute)